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High protein diets are increasingly popularized in lay media as a promising strategy for weight loss by providing
the twin benefits of improving satiety and decreasing fat mass. Some of the potential mechanisms that account for
weight loss associated with high-protein diets involve increased secretion of satiety hormones (GIP, GLP-1), reduced
orexigenic hormone secretion (ghrelin), the increased thermic effect of food and protein-induced alterations in
gluconeogenesis to improve glucose homeostasis. There are, however, also possible caveats that have to be considered
when choosing to consume a high-protein diet. A high intake of branched-chain amino acids in combination with a
western diet might exacerbate the development of metabolic disease. A diet high in protein can also pose a
significant acid load to the kidneys. Finally, when energy demand is low, excess protein can be converted to
glucose (via gluconeogenesis) or ketone bodies and contribute to a positive energy balance, which is undesirable if
weight loss is the goal. In this review, we will therefore explore the mechanisms whereby a high-protein diet may
exert beneficial effects on whole body metabolism while we also want to present possible caveats associated with the
consumption of a high-protein diet.
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Diets high in protein have been shown to be a potential
tool for weight loss [1]. General dietary guidelines for
adults suggest an acceptable macronutrient distribution
range (AMDR) of 45-65% of total energy from carbohy-
drates (CHO), 20-35% from fat (F), and 10-35% from
protein (P) with a recommended dietary allowance (RDA)
of 46 and 56 g/d or 0.8 g/kg body weight (BW) of P for fe-
males and males, respectively [2]. A diet is therefore con-
sidered high in protein if it exceeds 0.8 g/kg BW or the
habitual 15-16% of total energy [3]. High-protein (and low
CHO) diets have recently received much attention in form
of the Atkins diet which is a non-energy-restricting, low
CHO (as low as 30 g/day), high-protein/high-fat diet [4],
the South Beach diet (low CHO/high protein diet), the
Stillman diet (low CHO/high protein/low fat) or the Zone
diet (low CHO/high protein) (Table 1) [5]. But also diets
high in protein but containing a normal amount of CHO* Correspondence: dh.pesta@gmail.com
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article, unless otherwise stated.(20% P, 50% CHO and 30% F) have been successfully used
to improve metabolic parameters, suggesting that weight-
maintenance depends on the protein content but not
necessarily on a low CHO content [6]. Now, millions of
people all around the world follow these popular diets.
In this critical review, nutrient-specific mechanisms of
protein-induced satiety for weight loss and preservation
of fat-free mass as well as possible caveats of a high-
protein diet will be discussed.Mechanisms of satiation with a short-term high-protein diet
Sustained satiety is a key component to induce a negative
energy balance and to promote weight loss. An ideal
weight loss strategy would promote satiety and maintain
basal metabolic rates despite a negative energy balance
and reduction in fat-free mass. Satiety is multifactorial and
influenced by many components including but not limited
to the endocrine system, the cognitive and neural system
as well as the gastrointestinal system. A diet high in
protein seems to be able to influence certain systems. The
hierarchy for macronutrient-induced satiating efficiency is
similar to that observed for diet-induced thermogenesis
(DIT): protein is the most satiating macronutrient followedntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Table 1 Popular high-protein diets and their
macronutrient composition
DIET CHO Fat Protein g/kg/d
Protein*
USDA recommend 45-65% 20-35% 10-35% 0.8
Atkins [4] 6% 59% 35% 2.3
South Beach [5] 28% 33% 39% 2.6
Stillman [5] 3% 33% 64% 4.3
Zone [5] 36% 29% 34% 2.3
High Protein, normal
CHO [6]
50% 30% 20% 1.3
*based on a 2000 kcal diet and a 75 kg person.
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effect is most significant after high-protein diets [8]. Based
on a visual analogue scale (VAS), which comprises a stand-
ard tool to measure subjective appetite and satiety [9], sati-
ety was significantly greater after a 60% protein meal than
after a 19% protein meal [10]. These findings were con-
firmed by Crovetti et al. who reported significantly greater
satiety after consumption of an isocaloric meal containing
68% protein compared with a 10% protein meal [11]. In-
creased satiety helps to decrease energy intake, which is a
requisite for successful weight loss. In general, increased
satiety has been observed after meals with a protein content
in the range of 25% to 81% [12].
Interestingly, different types of protein induce distinct
effects on satiety and responses of (an)orexigenic hormones.
Also the mechanism of satiety is different, especially for
whey and casein proteins. Hall et al. compared whey and
casein protein and reported decreased energy intake from
a buffet meal offered after 90 min after whey protein in-
gestion, indicating an increased satiety response to whey
[13]. As the absorption of casein is slower due to clot for-
mation, 90 min may be too short to make the conclusion
of increased satiety. Veldhorst et al. [14] compared the
satiating effects of either 10% or 25% of energy from
casein-, soy-, or whey-protein. At 10%, whey provoked the
strongest reduction in hunger followed by casein and soy.
Decreased hunger rates coincided with higher leucine, ly-
sine, tryptophan, isoleucine, and threonine responses with
this protein type. For the 25% protein intake, the authors
report larger responses in hormone concentrations for
whey-protein as compared to casein- or soy-protein.
When Hochstenbach-Waelen et al. [15] compared the
effects of 2 diets with either 25% or 10% of energy from
casein, they report increased energy expenditure, protein
balance, satiety, and negative fat balance with the 25%
casein diet as compared to the 10% diet, indicating a
dose-dependent satiating effect for this type of protein.
Diepvens et al. [16] examined the effects of whey protein,
pea protein hydrolysate, a combination of whey protein
and pea protein hydrolysate and control milk protein (80%casein and 20% whey) on appetite ratings and satiety hor-
mones. They found that pea protein hydrolysate was most
effective in suppressing hunger, followed by whey protein,
as compared to milk protein. Surprisingly, these findings do
not correlate with changes in satiety hormones, which were
stimulated more by milk proteins, indicating that peptide
hormone response does not always correlate with perceived
satiety. Nieuwenhuizen et al. [17] hypothesized that trypto-
phan (Trp) which serves as a precursor for the anorexigenic
neurotransmitter serotonin, would contribute to the satiat-
ing effect of this amino acid in dietary proteins. When com-
paring alpha-lactalbumin (high in Trp), gelatin (low in Trp)
or gelatin with added Trp (high in Trp), the authors report
that the breakfast containing alpha-lactalbumin suppressed
hunger more than a gelatin or gelatin + trypthophan break-
fast. This observation, however, was independent of Trp
concentrations. In conclusion, it seems that different types
of proteins exert distinct effects on satiety and appetite rat-
ings, mediated by a nutrient-specific secretion of hormones.
These differences between the proteins seem to be related
to timing and certain amino acid threshold levels.
To assess the nutritional value of dietary proteins con-
sidering the protein source and dietary indispensable amino
acid content, the digestible indispensable amino acid score
(DIAAS) has been established as a new protein quality
measure to replace the protein digestibility-corrected amino
acids score (PDCAAS) [18]. It is derived from the ratio
between the amount (mg) of digestible dietary indispens-
able amino acid in 1 g of the dietary protein and the
amount (mg) of the same dietary indispensable amino acid
in 1g of the reference protein. The DIAAS can have values
below or in certain circumstances above 100%. Values
above 100% should not be truncated as was done for the
PDCAAS [19], except when the DIAAS is calculated for
protein or amino acid intakes for mixed diets or sole
source foods. In general, protein quality, digestibility and
utilization by the human body is highest in proteins from
animal sources such as meat, milk and egg, followed by
legume plant protein such as soy with cereal protein such
as wheat concluding this list [20].
Several factors contribute to increased protein-induced
satiety in response to a short-term high-protein intake.
The most important ones seem to be i) increased energy
expenditure, increased concentrations of ii) anorexigenic
hormones, and iii) metabolites such as amino acids and iv)
altered gluconeogenesis. High protein diets can therefore
favorably alter the energy balance equation. Enhanced sati-
ety allows for decreased food intake while an increased
thermic effect allows for greater calorie output.
Energy expenditure
The thermic effect of food, also called diet-induced
thermogenesis (DIT), is a metabolic response to food.
Food intake results in a transient increase in energy
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ent processing (i.e. digestion, absorption, transport, metab-
olism and storage of nutrients). The DIT is mostly
indicated as percentage increase in energy expenditure
over the basic metabolic rate (BMR). DIT values are
highest for protein (~15-30%), followed by CHOs (~5-10%)
and fat (~0-3%) [21,22]. Based on a recent meta-analysis,
the thermic effect of food increases ≈ 29 kJ/4184 kJ of
ingested food for each increase of 10 percentage points in
the percentage of energy from protein [23]. In other words,
if a subject therefore consumes an 8368 kJ/d diet with 30%
energy from protein, then the thermic effect of food will be
58 kJ/d higher than if protein contributes only 20% of the
dietary energy. This is only an estimate while actual mea-
surements can be higher, as shown below.
The high DIT of protein therefore affects energy bal-
ance. Whitehead et al. [24] used a room calorimeter to
assess 24-h energy expenditure in subjects on a high-
protein diet (36% energy from protein) against two with
15% energy from protein, one high in carbohydrate and the
other high in fat. The authors reported that energy expend-
iture was 297 kJ/d higher in subjects consuming the high-
protein diet (P < 0.05), which was in agreement with
the increase in sleeping metabolic rate. Mikkelsen et al.
[25] found that subjects consuming a diet containing 29%
of protein had a 891 kJ/d higher resting metabolic rate
than subjects consuming the same eucaloric diet with
11% energy from protein. For weight loss, however,
DIT-related satiety is even more important. A high protein
diet is associated with increased 24-h diet-induced energy
expenditure [26]. The increase in DIT may increase satiety.
A potential mechanism to account for this observation is
the increase in oxygen demand to metabolize proteins,
which can enhance satiety [26]. A similar phenomenon
of appetite suppression can be observed at high altitude
where oxygen is limited [27]. This increased oxygen
demand stems from the high postprandial amino acid
oxidation rate which is of even greater importance if
amino acids are given in excess of their deposition.
Satiety hormones
There are other possible mechanisms to explain the im-
provement in satiety with high-protein diets. Early obser-
vations that glucose was more expediently metabolized
after an oral load versus a matched intravenous load
led to the discovery and characterization of the incretin
hormones. Two key incretins are glucose-dependent insu-
linotropic polypeptide (GIP) and glucagon-like peptide-1
(GLP-1). These hormones are synthesized in the gut and
secreted from enteroendocrine cells in the intestinal
epithelium in response to an oral nutrient load [28]. The
release of the two incretin hormones potentiates glucose-
stimulated insulin release from the beta-cells [29]. Incretins
potentiate glucose disposal by stimulating insulin secretion,estimated to account for at least 50% of the total post-
prandial insulin release [30,31]. Besides their insulinotropic
action, GLP-1 inhibits glucagon secretion in a glucose-
dependent manner, thus diminishing postprandial glucose
excursions [29]. Extrapancreatic effects of GLP-1 include
inhibition of gastrointestinal motility and secretion and
thereby regulation of appetite and food intake.
Cholecystokinin (CCK) is a peptide hormone found in
the brain and the gastrointestinal tract [32]. CCK stimulates
intestinal motor activity and significantly contributes to the
inhibition of gastric emptying. Ingestion of dietary protein
and especially digestion (hydrolisation) of proteins into
amino acids effectively stimulates CCK release in the gut
[33]. It is now clear that CCK reduces food intake and
meal size and induces satiety [34] in a variety of mamma-
lian species including rats, rhesus monkeys and humans.
Brennan et al. [35] reported suppressed energy intake in
lean and obese subjects after high-protein meals, an effect
potentially mediated by CCK and ghrelin. The short-term
meal-related satiety signal of the peptide is most likely me-
diated through the CCKA receptor [36] and may involve
other satiety players such as insulin and leptin [37]. CCKs
functions include stimulation of pancreatic secretion,
gallbladder contraction and intestinal mobility as well
as inhibition of gastric emptying [38].
A recent study showed that GLP-1 blunted postprandial
glucose response and reduced insulin release by reducing
gastric emptying at physiological doses in response to
a mixed meal. This increased gastric retention, lowered
hunger and the desire to eat and augmented satiety [39].
The process of gastric emptying might play an important
role in the perception of hunger and satiety. In the same
study, GIP reduced postprandial glucose increment pri-
marily through an increased insulin release with no effect
on the gastric emptying rate [39]. GIP contributes to the
regulation of glucose uptake and stimulates triglyceride
storage in adipocytes [40]. Chronic exposure to incretin
mimetics leads to weight reduction in type 2 diabetics [41].
The ubiquitous serine protease dipeptidyl peptidase-4
(DPP-4) is responsible for the degradation of these pep-
tides. While incretin mimetics do promote weight loss, the
effect of DPP-4 inhibitors on weight control is less clear.
Nevertheless, pharmacological inhibition of DPP-4 activity
may be a strategy to decrease appetite and improve the
condition of type-2-diabetes. Inhibition of DPP-4 activity
by certain foods is therefore of great importance for med-
ical nutrition therapy. It was shown that the tripeptide
Ile-Pro-Ala (IPA) generated by proteinase K mediated pro-
teolysis of the whey protein component beta-lactoglobulin
can act as a DPP-4 inhibitor, thereby delaying GIP and
GLP-1 degradation [42]. It was suggested by the authors
that after luminal degradation, the IPA fragments may
act in situ as competitive inhibitors of DPP-4 as it cleaves
peptides with an N-terminal alanine or proline amino acid
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as pharmacological DPP-4 inhibitors such as Sitagliptin. In-
creased incretin levels mediate postprandial insulin release,
thereby inducing satiety [44] and the preference for food-
related cues [45].
The secretion of gut neuropeptides that induce satiation,
GLP-1, CCK, and peptide YY (PYY) seem to be increased
in response to a high-protein diet whereas concentrations
of orexigenic hormones such as ghrelin seem to be re-
duced [46,47]. Enteroendocrine cells which release GLP-1
and GIP are in direct contact with the gut lumen and by
this means seem to be able to sense arrival and passage of
nutrients along the gastrointestinal tract. Studies involving
human enteroendocrine cell lines have shown that essen-
tial amino acids (after hydrolytic digestion of complex
proteins) activated p38 MAPK and ERK1/2 pathway result-
ing in nutrient-stimulated GLP-1 release [48]. It has to be
noted, however, that GLP-1 secretion is nutrient related
(increased after a protein meal in combination with CHOs)
[49]. These gut neuropeptides were increased in women
fed a high protein diet (30% P/40% CHO/30% F) when
compared to an adequate protein diet (10% P/60% CHO/
30% F) [46]. Increased GLP-1 concentrations were also
found in men after a high protein breakfast, lunch and
dinner [50]. A study in humans by Blom et al. showed
increased satiety due to decreased postprandial ghrelin
concentrations in response to a high-protein breakfast
compared to an isocaloric high-carbohydrate breakfast
[51]. It is very likely that increased protein-induced sa-
tiety leads to reduced subsequent energy intake which
is beneficial for weight loss. This effect is not related to a
conditioned taste aversion. A decreased gastric empty-
ing rate following a high-protein diet has also been ob-
served [52].
Plasma amino acid levels
High-protein diets may directly promote a satiety response.
In 1956 the aminostatic hypothesis was introduced: in-
creased serum amino acid concentrations produced feel-
ings of satiety whereas decreasing concentrations created
feelings of hunger [53]. Diets high in protein will elevate
concentrations of plasma amino acids [54]. According to
Nefti et al. high intake of protein induces a vagal feedback
to the satiety center of the nucleus tractus solitarius in the
brainstem and the hypothalamus to suppress hunger [55].
Poppitt et al. [56] showed that the satiating effect after a
high-protein preload was significantly larger than preloads
containing an iso-energetic amount of carbohydrates or
fats. Along these lines, Westerterp-Plantenga [26] found a
significant increase in 24-h satiety in subjects consuming a
high-protein diet compared to a high-fat diet. The amino-
static hypothesis has been supported by several, but not
all studies [57], showing that high-protein diets result
in higher levels of satiety, however, complex homeostaticmechanisms between the peripheral organs and the
central nervous system which cause the aminostatic effect
are not yet fully understood. More research in this area is
necessary to elucidate this hypothesis.
Gluconeogenesis
Alteration of gluconeogenesis has been found to contribute
to satiety [58]. High-protein and low-carbohydrate diets
promote hepatic gluconeogenesis to maintain plasma
glucose levels. Two key enzymes of gluconeogenesis,
phosphoenolpyruvate carboxykinase (PEPCK) and glucose-
6-phosphatase (G6P), are upregulated in rats fed a high-
protein diet, suggesting that gluconeogenesis is stimu-
lated by a high-protein diet [59]. A modulation of hepatic
gluconeogenesis and increased glucose homeostasis could
be responsible for the satiating effect in this animal
model [60]. Veldhorst et al. [61] also report an increase in
gluconeogenesis in healthy men in response to a high-
protein diet as compared to a normal protein diet. A re-
cent study in humans found an increased gluconeogenesis
following high-protein intake but this increase was unre-
lated to appetite suppression [62]. Instead, the authors
observed an increased production of ketone bodies (espe-
cially beta-hydroxybutyrate) in response to the high-protein
diet. The increased concentration of beta-hydroxybutyrate
may act as an appetite suppressing substrate [62]. The latter
may be most important in contributing to increased satiety,
especially if the diet is high in protein and low in CHOs. It
is also well established that a decreasing level of blood
glucose is an appetite stimulating state whereas amino-acid
induced gluconeogenesis acts as appetite suppressant
preventing hypoglycemia. Central mechanisms include
augmented activation of Pro-opiomelanocortin (POMC)
neurons and alpha-melanocyte-stimulating hormone and
decreased activation of non-POMC neurons upon acute
ingestion of a high-protein diet. Intraduodenal protein
can activate vagal afferent fibers and after high-protein
ingestion c-Fos expression in neurons of the nucleus of
the solitary tract was increased [58].
The effect of a high-protein diet on body composition
and weight loss
High-protein diets can help preserve lean body mass dur-
ing weight loss. Mettler et al. examined the effect of in-
creased dietary protein intake (~2.3 g/kg BW/d) on lean
body mass maintenance during hypoenergetic weight loss
in athletes [63]. Performance parameters were not affected
in the subjects, most likely due to the short study period.
They found that though both groups lost similar amounts
of fat mass, lean body mass during the short 2 week study
period was preserved in the high-protein group compared
to the control group (~1 g/kg BW/d). In this study, the
authors balanced energy by changing fat intake and not
carbohydrate intake as is usually the case. Glucose intake
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effect of insulin on lipolysis in adipose tissue leads to
the postprandial suppression of fat oxidation [64]. This
inverse relationship between dietary carbohydrate intake
and fat oxidation may explain why Mettler did not observe
differences in fat loss between groups whereas others ob-
served reductions in fat mass in non-athletic, overweight
subjects on a high-protein (low-carbohydrate) diet [65,66].
Table 2 shows examples of foods high in protein relative
to their carbohydrate and fat content. A recent meta-
analysis of 18 randomized controlled trials found that
older adults (50+ years) can preserve lean body mass
during weight loss more effectively when they consume
a high-protein diet [67].
With regard to the macronutrient distribution, it appears
that there is a difference whether protein is increased at
the expense of CHO or fat. Increasing protein at the ex-
pense of CHOs leads to increased contribution of amino
acids to energy expenditure with a concomitant decrease
in lipogenesis due to decreased supply of dietary glucose
[68] and likely has a negative impact on exercise perform-
ance and training intensity [69]. Carbohydrate supply is
critical for strength and endurance performance. Athletes
should therefore be aware about limited energy intake and
maintenance of training levels. For obese subjects, lowering
carbohydrate in favor of protein might be advantageous
as dietary CHOs might impair fat oxidation [70] whereas
low-CHO, high-protein diets reduce adipose tissue devel-
opment [71]. Higher daily protein intake at the expense
of fat intake could substantially reduce total energy in-
take, which could possibly translate to a healthier weight
status [72].
Long-term effects of high-protein diets depend on the
population studied as well as the exact composition of
the diet but have generally been shown to include weight
reduction and weight loss maintenance as well as benefi-
cial effects on metabolic risk factors such total cholesterol
and triacylglycerol. Claessens et al. [73] compared a low-fat,
high-carbohydrate diet against a low-fat, high-protein
diet. The authors conclude that after 12 weeks of dietTable 2 High-protein foods relative to their carbohydrate
and fat content






Wheat gluten 75 1.8 14
Textured vegetable protein 48 0 28
Cottage cheese 11 4.3 3.4
Greek yoghurt 10 0.4 3.6
Egg 13 11 1.1
Lentils 9 0.4 20
Edamame 11 5 10
Split peas 25 1.2 60intervention, the low-fat, high-protein diet was more effect-
ive for weight control. Clifton et al. [74] analyzed data from
215 obese subjects which were either assigned to a 12 week
high-protein or standard-protein diet. The authors con-
clude that subjects in the high-protein group had beneficial
effects on total cholesterol and triacylglycerol and achieved
greater weight loss and better lipid results. In another
study, Clifton et al. [75] determined the efficacy of a high-
protein and high-carbohydrate intake on the maintenance
of weight loss after 64 weeks of follow-up. The authors
found no significant difference between groups regarding
weight loss. Protein intake in grams derived from the diet-
ary records, however, was directly related to weight loss
[75]. Westerterp-Plantenga et al. [76] studied that effect of
a 20% higher protein intake (18% of energy vs 15% of en-
ergy) for subsequent 3 months of weight maintenance after
weight loss. They found that higher protein intake resulted
in a 50% lower body weight regain over this time, possibly
related to increased satiety and decreased energy efficiency
[76]. It has to be mentioned, however, that a hypochaloric
diet with a high protein content of 20-30% is only relatively
high in protein compared to a eucaloric diet with a normal
protein level of 10-15% while the absolute amount of pro-
tein often does not differ between the two diets [77].
The mechanisms by which increased long-term dietary
protein intake regulate body weight are not well under-
stood but are most likely multifactorial. Depending on the
diet, lower triacylglycerol levels and hence fat mass loss
with a higher-protein diet as well as increased satiety
possibly mediated by increased leptin sensitivity have
been discussed [75,78,79]. Fluid loss related to reduced
carbohydrate intake and overall caloric restriction have
also been discussed to mediate weight loss [5].Possible caveats of a high-protein diet
Metabolomics studies revealed that high intake of
branched-chain amino acids (BCAAs, Valine, Leucine,
Isoleucine) and aromatic amino acids (Phenylalanine,
Tyrosine) may be associated with the development of
metabolic diseases [80]. Importantly, this only occurs in
combination with a high-fat diet. BCAA supplementation
contributes to accumulation of intermediates propionyl-
CoA and succinyl-CoA, which are a catabolic byproduct of
BCAA degradation. High catabolic flux of these intermedi-
ates interferes with appropriate oxidation of fatty acids,
possibly by allosteric inhibition of citrate synthase [81]
which slows down the TCA cycle, causing buildup of
incompletely oxidized substrates such as acylcarnitines.
This accumulation leads to mitochondrial stress, impaired
insulin action, and finally to perturbation of glucose
homeostasis [80]. This connection might be highly rele-
vant as many overweight people worldwide are effectively
on a high-fat diet but might as well do weight-training and
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caloric intake from fat BCAA supplementation might
exacerbate the risk of metabolic disease.
Diets high in protein pose a potential acid load to the
kidneys, mainly as sulfates and phosphates [82]. It was
hypothesized that calcium and hence bone mass was lost
in order to buffer this acid load [83]. Although the bone-
loss hypothesis has been refuted and there is agreement
that high-protein diets are actually favorable to intestinal
calcium uptake, bone health and bone mineral density
[84], the protein-induced acid-load to the kidneys remains,
e.g. as sulfuric acid from the oxidation of methionine and
cysteine. This phenomenon is especially prominent in
diets such as the Atkins diet which can lead to additional
acid buildup from ketone bodies in response to reduced
carbohydrates and concomitantly increased fat and pro-
tein intake. Frank et al. [85] assessed the effect of short-
term increased oral protein ingestion on renal function,
hemodynamics, and clinical-chemical variables in healthy
young men. They reported significant changes in the
glomerular filtration rate, the filtration fraction, albuminuria,
serum uric acid, and urinary pH values in the high-protein
diet group. The authors conclude that renal hemodynamics
and renal excretion is altered in response to a short-term,
high-protein diet. Although depended on the source of
protein, interventional studies in humans have shown that
high-protein diets have the potential to increase the risk of
calcium stone-formation in the urinary tract [82,86]. In
order to maintain an acid–base balance in the body, people
on a high-protein diet should consider ingestion of alkali
buffers such as fruits and vegetables high in potassium
(alkaline-forming foods). Glutamine or sodium bicarbonate
supplements can also help to restore acid–base balance in
the body. In general, people experimenting with high-
protein diets are advised to monitor their renal function.
People on high-protein diets are advised to choose their
source of protein very carefully (i.e. emphasize the use of
high-quality protein sources from plant origin). Many
protein-rich foods of animal origin (e.g. red meats, eggs
and dairy products) also contain high levels of saturated
fats and cholesterol. This may put consumers of high-
protein diets at higher risk for heart disease, hyperlipidemia
and hypercholesterolemia [87]. Healthier proteins from
vegetables (soy protein, beans, tofu, seitan or nuts) or fish
could be a valuable alternative. Finally, all excess protein will
eventually be converted to glucose (via gluconeogenesis) or
ketone bodies [88,89]. This may also explain the increased
gluconeogenesis in response to a high-protein diet, as
described above. In a state of low energy demand, these
metabolites will be stored as glycogen and fat, which is
undesirable if weight loss is the goal. Along these lines,
weight loss can only be achieved by establishing a negative
calorie balance, though this may be more tenable on a
high-protein diet.Conclusion
Whereas diets high in protein have considerable beneficial
effects on satiety and weight control, which is of great
interest to e.g. obese individuals, there are some caveats to
high protein diets such as increased acid load to the
kidneys or high fat content of animal proteins. Awareness
of these caveats enables individuals choosing to consume
a high-protein diet to get the most benefit from it.
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